Active ingredientNemonoxacinCat. No. P-N033-001CAS 378746-64-6Family · Pharmaceutical analytical standards
Nemonoxacin
An antibiotic of the quinolone family that blocks bacterial topoisomerases, first approved in Taiwan in 2014, as an oral medicine, for community-acquired bacterial pneumonia. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It is a 'non-fluorinated' quinolone: unlike ciprofloxacin and levofloxacin it lacks the fluorine atom at position 6 that gives fluoroquinolones their name.
Go to the active ingredient →Active ingredientNemonoxacinCat. No. P-N033-001CAS 378746-64-6
Isotopically labelledNemonoxacin-13C,d3Cat. No. P-N033-002
ImpurityNemonoxacin Impurity 1Cat. No. P-N033-003CAS 2770004-80-1
ImpurityNemonoxacin Impurity 2Cat. No. P-N033-004CAS 2770004-79-8
ImpurityNemonoxacin Impurity 3Cat. No. P-N033-005CAS 2770004-81-2
ImpurityNemonoxacin Impurity 4Cat. No. P-N033-006CAS 2770004-82-3
ImpurityNemonoxacin Impurity 5Cat. No. P-N033-007CAS 378746-65-7
ImpurityNemonoxacin Impurity 6 DihydrochlorideCat. No. P-N033-010CAS 221221-40-5No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.